MarketWatch3m
Comcast Confirms $7B Spinoff of NBCUniversal Cable Channels
Comcast said it plans to spin off its NBCUniversal cable-television networks, confirming an earlier report by The Wall Street Journal. The company said Wednesday it intends to create a new publicly ...
TJX’s earnings boosted by strength in Europe as earnings beat and retailer raises guidance
TJX Cos. Inc.’s stock moved between gains and losses early Wednesday, after the discount retailer’s fiscal third-quarter ...
Nvidia stock options brace for earnings volatility, but not anymore than usual
The options market is ready for another volatile move in Nvidia's stock on the day after earnings, but just a touch below the historical average. "Straddle" options, [which are bets on movement but no ...
This is the big 'whisper' number for Nvidia's guidance
The FactSet consensus models $37.1 billion in revenue for Nvidia's January quarter. But what sort of beat are investors looking for when it comes to Nvidia's guidance? The "whisper" number among ...
S&P 500 Futures Climb in Premarket Trading; Target, Fabrinet Lag
With U.S. stock markets set to open in two hours, Dolby Laboratories Inc. Cl A (DLB) was up 12.8% in pre-market trading, and Wix.com Ltd. (WIX) was up 11.0%.
T.J. Maxx Parent Bumps Up Outlook After 3Q Sales Climb
T.J. Maxx parent TJX recorded higher earnings in the third quarter as customer traffic drove sales up, prompting the company to raise its full-year guidance. The owner of off-price retail chains ...
Lifeway Foods Rejects Sweetened Danone Buyout Bid
Lifeway Foods has rejected a sweetened buyout bid from top shareholder Danone, once again saying the French company's proposal substantially undervalues the maker of probiotic foods. Danone, which ...
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...
Sage Therapeutics' stock falls after therapy fails for a third time
Sage Therapeutics Inc.’s stock fell 2% early Wednesday after the company said it would cease the development of a treatment for cognitive impairment associated with Huntington’s disease after a failed ...
NewAmsterdam Pharma Phase 3 Drug Combo Study Hits Main Endpoints
NewAmsterdam said the Phase 3 study of a fixed-dose combination of obicetrapib and ezetimibe met all co-primary endpoints in reduction in low-density lipoprotein cholesterol in adults with ...
Sage Therapeutics to end Huntington’s disease trial after key therapy fails again
It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...
Powell Industries Shares Fall as New Orders Slip Sequentially
The Houston company late Tuesday said fourth-quarter new orders totaled $267 million, compared with $171 million a year earlier and $356 million in the third quarter. Its backlog totaled $1.3 billion ...